Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Pathology: Research and Practice

Volume  6, Issue 2 (Part-2), APRIL - JUNE 2017, Pages 415-420
 

Original Article

Glycated Hemoglobin [HbA1C] As a Dual Marker for Glycemic Status and Dyslipidemia in Diabetics: A Cross Sectional Analysis of 450 Cases

Lavanya Rajagopal*, Balaji Ramraj**, Sundaram Arunachalam***, Veena Raja*, Shivashekar Ganapathy****

*Assistant Professor ***Dean (Medical) Professor ****Professor and HOD, Department of Pathology **Associate Professor, Department of Community Medicine, SRM Medical College Hospital and Research Centre, Kattankulathur, Chennai 603203. India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.62(pt-II)17.13

Abstract

 
Background: The prevalence of dyslipidemia in diabetes mellitus [DM] is 95%. Diabetic patients with accompanied dyslipidemia are soft targets of cardiovascular deaths. Glycated Hemoglobin [HbA1C] the gold standard for assessing the glycemic status, has been regarded as an independent risk factor for Coronary Heart Disease [CHD] and stroke. Various studies have contradicting results on the impact ofHbA1C levels on lipid profile in diabetics. Aim: To find out association between glycemic control (HbA1C), age, gender and serum lipid profile in type 2 diabetic patients and non-diabetic subjects. Materials and Methods: A cross-sectional study carried out in SRM Hospital and Research Centre, Chennai. Total 450 subjects (150 controlled & 150 poorly controlled diabetics, 150 non-diabetics) with equal number of males and females in each group and investigated for HbA1C and lipid profile. Statistical Analysis: The data were analyzed by SPSS version 21 using Independent samples student ‘t’ test. ‘p’ value <0.05 was considered as statistically significant. Results: There was a significant increase in mean Total Cholesterol [TC], Triglyceride[TG], Low Density Lipoprotein Cholesterol [LDL-C], Fasting Blood Glucose [FBG] levels and HbA1C between non-diabetics, controlled and poorly controlled diabetics. But High Density Lipoprotein-Cholesterol [HDL-C] was not significant between these study groups. TC, TG, LDL-C levels between males and females in each group were not statistically significant. But mean HDL-C was non-significantly lower in female diabetics. Subjects with worse glycemic control (HbA1C >9%) possessed significantly high values of TC, TG, LDL-C, FBG except HDL-C. No significant correlation for age with respect to serum lipid profile. Conclusion: We conclude, HbA1C predicts dyslipidemia . This highlights the usefulness of HbA1C as dual biomarker (glycemic control and lipidemic state) for screening high risk diabetic patients.

Keywords: Glycated Hemoglobin (HbA1C); Dyslipidemia; Diabetes.


Corresponding Author : Lavanya Rajagopal